期刊文献+

反义寡核苷酸对淋巴瘤细胞Livin基因表达及细胞凋亡的影响 被引量:1

Effects of antisense oligodeoxynucleotide on the expression of livin gene and the apoptosis of lymphoma cell
下载PDF
导出
摘要 目的分析凋亡抑制蛋白Livin基因的反义寡核苷酸(ASODN)对人淋巴瘤细胞株(Raji)Livin mRNA表达的抑制作用及其对细胞凋亡的影响。方法合成Livin特异性全硫代修饰的ASODN及其对照错义寡核苷酸(MSODN),通过脂质体转染Raji细胞,MTT法检测细胞的增殖抑制率;RT-PCR法检测转染前后Livin mRNA表达水平的变化;Hoechst染色观察细胞凋亡的形态学改变;流式细胞仪检测细胞的凋亡率。结果 Livin ASODN能显著抑制Raji细胞的增殖(P<0.01),并呈现一定的剂量效应关系。0.6μmol/L的ASODN作用Raji细胞48h后,Livin mRNA的表达水平明显下调,细胞出现凋亡的形态学改变,细胞凋亡率为(37.54±2.65)%,与对照组比较,差异有统计学意义(P<0.01)。结论 Livin ASODN能有效降低Livin mRNA表达水平,抑制Raji细胞增殖,并增强细胞凋亡的敏感性,有望成为淋巴瘤基因治疗的分子靶向。 【Objective】This study was intended to explore the effects of antisense oligodeoxynucleotide(ASODN) on the inhibition of Livin gene expression and apoptosis of human lymphoma cell line(Raji).【Methods】Livin specific phosphorothioate antisense oligodeoxynucleotide and missense oligodeoxynucleotide were synthesized and transfected into Raji cells with liposome.MTT assay was used to detect the proliferation inhibition rate of Raji cells.The expression level of Livin mRNA in Raji cells was detected by RT-PCR.The morphologic changes of cell apoptosis were observed by Hoechst fluorescein staining.Apoptosis rate of Raji cells was examined by flow cytometer.【Results】Livin ASODN obviously inhibited the proliferation of Raji cells in a dose-dependent manner(P 0.01).After transfection of 0.6 μmol/L ASODN,the expression of Livin mRNA was decreased and the apoptosis rate was(37.54± 2.65)%.The differences were significant when compared with the other control groups(P 0.01).【Conclusion】Livin ASODN remarkably down-regulates the expression of Livin gene and supresses the proliferation and induces the apoptosis of Raji cells,which may be a molecular target for gene therapy of lymphoma.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第16期2421-2424,共4页 China Journal of Modern Medicine
基金 广西青年科学基金项目(桂科青0640042) 广西大型仪器协作共用网资助项目(No:539-2007-118)
关键词 LIVIN基因 反义寡核苷酸 淋巴瘤 细胞凋亡 livin gene antisense oligodeoxynucleotide lymphoma cell apoptosis
  • 相关文献

参考文献11

  • 1WU H, MA Y, ZHU Y, et al. Expression of BIRC7 protrin and mRNA in non-Hodgkin's Lymphoma [J]. Leuk Lymphoma, 2006, 47(6): 1110-1116.
  • 2顾永耀,贺菽嘉,冯振博,王华.凋亡抑制因子Livin在白血病和淋巴瘤细胞株中的表达[J].山东医药,2008,48(45):41-42. 被引量:1
  • 3张华东,袁守军,陈惠鹏,田增月,韩昌明.Livin mRNA的反义核酸诱导MCF-7乳癌细胞凋亡作用(英文)[J].中国临床药理学与治疗学,2004,9(12):1353-1356. 被引量:14
  • 4KIM DK, ALVARADO CS, ABRAMOWSKY CR, et al. Expression of inhibitor-of-apoptosis (IAP) Livin by neuroblastoma cells: correlation with prognostic factors and outcome [J]. Pediatr Dev Pathol, 2005, 8(6): 621-629.
  • 5KEMPKENSTEFFEN C, HINZ S, CHRISTOPH F, et al. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome [J]. Turnout Biol, 2007, 28(3): 132-138.
  • 6LIU HB, KONG CZ, ZENG Y, et al. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment[J]. Urol Oncol, 2009, 27(3): 277-283.
  • 7HARIU H, HIROHASHI Y, TORIGOE T, et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer [J]. Clin Cancer Res, 2005, 11(3): 1000-1009.
  • 8YAGIHASHI A, OHMURA T, ASANUMA K, et al. Detection of autoantibodies to Survivin and Livin in sera from patients with breast cancer[J]. Clin Chim Aeta, 2005, 362(1-2): 125-130.
  • 9KITAMURA H, HONMA I, TORIGOE T, et al. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients[J]. Urology, 2007, 70(1): 38-42.
  • 10WANG R, LIN F, WANG X, etal. Silencing Livin gene expression to inhibit proliferation and enhance chemosensifivlty in tumor cells[J]. Cancer Gene Ther, 2008, 15(6): 402-412.

二级参考文献15

  • 1Kim DK, Alvarado CS, Abramowsky CR, et al. Expression of inhibitor-of-apoptosis (IAP) Livin by neuroblastoma cells: correlation with prognostic factors and outcome [ J]. Pediatr Dev Pathol, 2005, 8(6) :621-629.
  • 2Gazzaniga P, Gradilone A, Giulianil L, et al. Expression and prognostic significance of Livin, Survivin and other apoptosis-related genes in the progression of superficial bladder cancer [ J ]. Annals Oncol,2003,14( 1 ) :85-90.
  • 3Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoantibodies to Survivin and Livin in sera from patients with breast cancer [ J ]. Clin Chim Acta, 2005,362 ( 1-2 ) : 125-130.
  • 4Andersen MH, Reker S, Becker JC, et al. The melanoma inhibitor of apoptosis protein : a target for spontaneous cytotoxic T cell responses [ J ]. J Invest Dermatol,2004,122 (2) :392-399.
  • 5Hariu H, Hirohashi Y, Torigoe T, et al. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer [ J ]. Clin Cancer Res, 2005,11 ( 3 ) : 1000-1009.
  • 6[1]Steller H. Mechanisms and genes of cellular suicide[J]. Science, 1995; 267(10): 1445-9
  • 7[2]Thompson CB. Apoptosis in the pathogenesis and treatment of disease[J]. Science, 1995; 267(10): 1456-62
  • 8[3]Lin JH, Deng G, Huang Q. KIAP, a novel member of the inhibitor of apoptosis protein family[J]. Biochemi Biophys Res Commun, 2000; 279(3): 820-31
  • 9[4]Vucic D, Henning R. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J]. Curr Biol, 2000; 10(21): 1359-66
  • 10[5]Kasof GM, Gomes BC. livin, a novel inhibitor of apoptosis protein family member[J]. J Biol Chem, 2001; 276(5): 3238-46

共引文献13

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部